Study Links Vaping to Disease-Causing Genetic Changes

Industry Insight by Vaping Post
Jun.02.2022
A recent study published in Scientific Reports, has linked vaping to changes in mitochondrial and immune response genes.

A novel role for vaping in mitochondrial gene dysregulation and inflammation fundamental to disease development,” the current study was conducted by a team of researchers at the Keck School of Medicine of USC. To conduct their analysis the researchers recruited a diverse group of 82 healthy adults and separated them into three groups: current vapers, with and without a prior history of smoking; people who exclusively smoke cigarettes; and a control group of never-smokers and never-vapers. 

 

They then conducted a number of biochemical tests to detect any changes in gene regulation and comprehensive interview so as to be able to link test results with their consumption behaviour. 

An article on News-Medical highlighted that on analysing the compiled data, the researchers found significant dysregulation of immune response genes in both vapers and smokers. However, the finding that was mostly emphasized on, is one based on computational modeling, suggesting “that ‘current’ vaping, but not ‘past’ smoking, is significantly associated with gene dysregulation in vapers.”

On the other hand, other tests indicated that smoking causes more genetic damage. “Comparative analysis of the gene networks and canonical pathways dysregulated in vapers and smokers showed strikingly similar patterns in the two groups, although the extent of transcriptomic changes was more pronounced in smokers than vapers. Of significance is the preferential targeting of mitochondrial genes in both vapers and smokers, concurrent with impaired functional networks, which drive mitochondrial DNA-related disorders. Equally significant is the dysregulation of immune response genes in vapers and smokers.”

A genetic predisposition to smoking initiation is associated with an increased risk of e-cig use

In other news, a recent study published on Plos Medicine looked into whether polygenic risk scores (PRS) for smoking initiation are associated with ever use of e-cigarettes. The study titled, “Association of genetic liability to smoking initiation with e-cigarette use in young adults: A cohort study,” aimed to determine whether the relationship between vaping and smoking is causal, or whether it exists due to shared factors that influence both behaviours, such as a genetic liability.

Smoking initiation PRS were calculated for 7,859 young adults. A total of 878 (30%) had ever used e-cigarettes at 24 years, and 150 (5%) were regular e-cigarette users at 24 years. The researchers looked for positive associations of similar magnitude between smoking initiation PRS and both smoking initiation and ever e-cigarette use by the age of 24 years, which would show that a genetic predisposition to smoking initiation is associated with an increased risk of e-cig use.

The compiled data did indeed find such an association. “Our results indicate that there may be a shared genetic aetiology between smoking and e-cigarette use, and also with socioeconomic position, externalising disorders in childhood, and risky behaviour more generally. This indicates that there may be a common genetic vulnerability to both smoking and e-cigarette use, which may reflect a broad risk-taking phenotype.”

 

Source:Vaping Post

Study Links Vaping to Disease-Causing Genetic Changes
On the Global Tobacco Battlefield: The Clash Between Science and Misinformation — A Tobacco Harm Reduction Expert’s Contribution to 2Firsts
On the Global Tobacco Battlefield: The Clash Between Science and Misinformation — A Tobacco Harm Reduction Expert’s Contribution to 2Firsts
In this in-depth contribution to 2Firsts, harm reduction expert Harry Shapiro exposes the misinformation and bias in global tobacco control, calling for evidence-based safer nicotine alternatives to protect public health and save lives.
Jul.08
2Firsts Analyzes UK's 2025 Purchasing Guide: Top 5 Products by Retail Sales & Profitability Parameters Revealed
2Firsts Analyzes UK's 2025 Purchasing Guide: Top 5 Products by Retail Sales & Profitability Parameters Revealed
According to the UK's 2025 Purchasing Guide report, 2Firsts has compiled the top five product SKUs in terms of convenience store sales rankings and the top five with the highest average weekly profit per store, along with a summary of their specifications.
Aug.12 by 2FIRSTS.ai
Heated Tobacco Battle Heats Up in South Korea: KT&G Launches Half-Price Promotion, PMI Ramps Up Marketing
Heated Tobacco Battle Heats Up in South Korea: KT&G Launches Half-Price Promotion, PMI Ramps Up Marketing
KT&G and Philip Morris Korea are locked in fierce competition in South Korea’s heated tobacco market. KT&G is offering its new Lil Solid Easy at half price, while Philip Morris is targeting youth through music festival campaigns. With just a 1% market share gap, the battle is intensifying.
Jul.04 by 2FIRSTS.ai
BAT Subsidiary Acquires Three More CHUC E-Cigarette Products in $1.5 Million Deal
BAT Subsidiary Acquires Three More CHUC E-Cigarette Products in $1.5 Million Deal
Charlie’s Holdings has amended its deal with BAT’s R.J. Reynolds Vapor, selling three more PACHA synthetic nicotine e-cigarette products for $1.5 million. This brings BAT’s total acquisition to 15 CHUC products submitted for PMTA since April.
Jul.07 by 2FIRSTS.ai
U.S. Tobacco Firm Cabbacis Secures Pod Patent for Low-Nicotine and Industrial Hemp Blends
U.S. Tobacco Firm Cabbacis Secures Pod Patent for Low-Nicotine and Industrial Hemp Blends
U.S. tobacco maker Cabbacis has secured a USPTO patent (No. 12,349,724) for oral vaporizer pods, effective until July 2038. With existing patents, its iBlend™ harm-reduction products—featuring low-nicotine and hemp blends—are now protected in over 30 countries and key global tobacco markets.
Jul.18 by 2FIRSTS.ai
Xinan Liu, Associate Researcher at the Brain Science Institute of CAS Shenzhen Institute of Advanced Technology, Speaks at 2Firsts Global NGP Rethink Forum
Xinan Liu, Associate Researcher at the Brain Science Institute of CAS Shenzhen Institute of Advanced Technology, Speaks at 2Firsts Global NGP Rethink Forum
Xinan Liu, Associate Researcher at the Brain Science Institute of the Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, delivered a keynote speech at the 2Firsts Global NGP Forum titled "The Global Opportunities and Challenges of The Novel Tobacco Industry from a Scientific Perspective".
Jul.30 by 2FIRSTS.ai